Caladan Bio makes automated benchtop bioreactor systems for fermentation and cell-culture teams, with a flagship product called the Caladan250, a high-throughput bioreactor that combines hardware, software, sensors, and automation in a single platform. The company says its systems are used by researchers who need higher-throughput experiments and more structured data for bioprocessing workflows. Caladan Bio was founded by Rob Jauquet and Mike Kobida, and sources also identify Mike Kobida as a key company leader. In 2024, the company raised a $5 million seed round; investors reported on the round included Collab Fund and Numenta?